Navigation Links
Viral Genetics Information Now Available Through OTCIQ.com and Pink Sheets Website
Date:7/8/2009

>

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Viral Genetics, Inc. from time to time in its periodic reports filed with the SEC. VGV-1 is not approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world. While Viral Genetics believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Viral Genetics to establish the efficacy of VGV-1 in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of VGV-1 in the United States, the obtaining of funding required to carry out the development plan, the completion of studies and tests on time or at all, and the successful outcome of such studies or tests. Therefore, there can be no assurance that the forward-looking statements included in this release will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the forward-looking statements should not be regarded as a representation by Viral Genetics or any other person that the objectives and plans of Viral Genetics will be achieved.

Contact: Viral Genetics, Haig Keledjian, 626-334-5310


'/>"/>
SOURCE Viral Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
2. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
3. Companys Partner Completes Trial Production of a New Antiviral Medicine
4. Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
5. SAFC Pharma to Increase Viral Product Manufacturing Capacity
6. MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study
7. Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
8. Peregrine Pharmaceuticals Reports Studies Published in Science Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
9. World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
10. Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
11. Researchers decode viral process that prepares cells for HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery ... a Memorandum of Understanding with the Feinstein Institute ... New York to collaborate with the ... The collaboration brings together the drug ... clinical expertise of the Feinstein Institute in neurosciences ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 LC ... proteomics technologies, announced today that it is seeking ... an innovative multiplex PCR based targeted sequencing technology. ... sequence analysis, that enables accurate detection of rare ... and Omega-Primer™ technologies. The company will collaborate with ...
(Date:4/16/2015)... Spirax Sarco, the leader in ... newly designed, state-of-the-art website in the first quarter ... promotes the Spirax Sarco brand, company capabilities, and ... a site visitor might be looking for including ... serviced, the latest company news, careers, and much ...
(Date:4/16/2015)... 16, 2015 Cambridge Semantics ... driven by Semantic Web technology, and Informa ... and services for the academic and scientific, professional ... joint solution ‘Smart Data Lake for Clinical Trial ... the 2015 Bio-IT ‘Best of Show’ Award. ...
Breaking Biology Technology:Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Spirax Sarco website has a new look 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3
... centralised genotyping diagnostic service to facilitate the identification ... commercial poultry flocks. The test will allow ... two isolates and thus provide statistically significant evidence ... any such virus from a source flock to ...
... at 4:30pm ET European Commission Decision ... Company to Provide Update on FDA review of Qutenza ... - CHMP issued positive opinion recommending approval ... pain in non-diabetic adults, either alone or in combination ...
... 25 Percent to $62.6 Million -- Conference Call Today ... 7 PDL BioPharma, Inc. (PDL) (Nasdaq: ... quarter ended March 31, 2009. Total revenues from continuing ... million, a 25 percent increase from $50.2 million for ...
Cached Biology Technology:Avian Adenovirus Genotyping Diagnostic Service 2NeurogesX Reports First Quarter 2009 Results 2NeurogesX Reports First Quarter 2009 Results 3NeurogesX Reports First Quarter 2009 Results 4NeurogesX Reports First Quarter 2009 Results 5NeurogesX Reports First Quarter 2009 Results 6NeurogesX Reports First Quarter 2009 Results 7NeurogesX Reports First Quarter 2009 Results 8NeurogesX Reports First Quarter 2009 Results 9NeurogesX Reports First Quarter 2009 Results 10NeurogesX Reports First Quarter 2009 Results 11PDL BioPharma Announces First Quarter 2009 Financial Results 2PDL BioPharma Announces First Quarter 2009 Financial Results 3PDL BioPharma Announces First Quarter 2009 Financial Results 4PDL BioPharma Announces First Quarter 2009 Financial Results 5PDL BioPharma Announces First Quarter 2009 Financial Results 6PDL BioPharma Announces First Quarter 2009 Financial Results 7PDL BioPharma Announces First Quarter 2009 Financial Results 8PDL BioPharma Announces First Quarter 2009 Financial Results 9
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:4/1/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces the second shipment of a ... early access pre-order customers. Feedback from ... including Walmart, Target, AT&T, Dunkin, Donuts, Stop & Shop ... all outlets and very easy to use. Several users ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
... Council (MRC) have discovered for the first time that two ... helping to identify how the body,s own cells fight back ... open-access journal PLoS Biology , could lead to future ... cells, an entirely new concept for cancer research. The ...
... Jay Kolls, Professor and Chairman of Genetics at the LSU ... awarded a $2.1 million grant over five years by the ... of Health to determine the role and identify which T-helper ... (PCP), which can be a complication of HIV/AIDS. It can ...
... Spanish . , A new beetle that could be ... identified by Agricultural Research Service (ARS) scientists and cooperators. ... Thailand by entomologists Bob Pemberton (now retired), with the ARS ... Wright, with the ARS Australian Biological Control Laboratory (ABCL) in ...
Cached Biology News:Divide and conquer: Genes decide who wins in the body's battle against cancer 2LSUHSC awarded $2 million dollar grant to prevent pneumonia linked to immune deficiency 2Scientists identify new potential biocontrol for skunk vine 2